Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $355.5400 (-2.43%) ($354.0000 - $364.7100) on Thu. Sep. 25, 2014. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.8% (three month average) | | RSI | 55 | | Latest Price | $355.5400(-2.43%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -0.4% a day on average for past five trading days. | | Weekly Trend | REGN advances 1.3% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
XLV(38%) XBI(37%) QQQ(31%) SPY(30%) XLK(28%) | | Factors Impacting REGN price | REGN will decline at least -0.9% in a week (0% probabilities).
VIXM(-13%) TLT(-6%) SHY(-3%) IGOV(-3%) UUP(-2%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.9% (StdDev 1.8%) | | Hourly BBV | 0 () | | Intraday Trend | -2.1% | | | | | |
|
| 5 Day Moving Average | $359.2(-1.02%) | | 10 Day Moving Average | $356.78(-0.35%) | | 20 Day Moving Average | $354.47(0.3%) | | To recent high | -2.4% | | To recent low | 28.2% | | Market Cap | $37.697b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |